CAPR

NASDAQ · Biotechnology

Capricor Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$33.50

+2.59 (+8.38%)

As of May 9, 1:35 AM ET ·

CAPR News2 articles

Market Movers: RELX, Capricor, and Global Tensions Shape Trading

RELX drops 8.8% in a week, Capricor soars 387% annually, US-Iran tensions drive crude oil volatility, and other key market movers on May 10, 2026.

Markets 11h ago

Capricor Shares Gain Ahead of Key Duchenne Data and Financial Update

Capricor Therapeutics shares advanced 7.6% as the company prepares to release quarterly results and full Phase 3 data for its Duchenne muscular dystrophy drug deramiocel on March 12.